Cassava Sciences Inc Equity-NMS: SAVA

$- -1.27 (January 1, 1970)

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$1.27
Open :$1.2
Today's high :$1.31
Today's low :$1.17
52W low :$1.17
52W high :$42.2
EPS(TTM): :-1.46
Shares O/S :48.31 M
Market cap :63.28 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Cassava Sciences Inc $- +0% - 63.28M

Frequently Asked Questions

What is the share price of Cassava Sciences Inc today?

Cassava Sciences Inc (SAVA) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Cassava Sciences Inc

Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, investigational treatments for central nervous system disorders, including Alzheimer’s disease and tuberous sclerosis complex (TSC)-related seizures. The Company's science is based on stabilizing, but not removing, a critical protein in the brain for patients with disorders such as Alzheimer’s disease or TSC. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease and TSC-related epilepsy. Simufilam targets an altered form of a protein called filamin A (FLNA) in the brain of patients with disorders such as Alzheimer’s disease or TSC. SavaDx, its lead investigational diagnostic product candidate, early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood.